Discover and read the best of Twitter Threads about #CardiogenicShock

Most recents (8)

🧵 Thread: The Future of Assessing Systemic Microcirculation in Cardiogenic Shock (CS) 🩺🫀

1/ Hey Twitterverse! Today, I want to talk about an exciting topic in cardiology & ICU: the role of evaluating systemic microcirculation in CS. 🌡️🫀 #ICU #Cardiology #Microcirculation Image
2/ CS is a life-threatening condition in which the heart is unable to pump enough blood to meet the body's metabolic needs.

academic.oup.com/ehjacc/article… Image
3/ Traditionally, assessment of the macrocirculation (e.g., BP, LVEF, CO) has been the focus, but new research suggests that assessment of the microcirculation is the next step.💡
Read 16 tweets
💡New research from our group @ESC_Journals indicates that #MCS might improve outcomes in patients with #heartfailure related #cardiogenicshock Let me walk you through it!
Actually, #cardiogenicshock has, for many years, been seen as predominantly caused by #myocardialinfarction However, recent evidence suggests that non-ischemic causes match it in frequency and impact on outcomes ‼️
pubmed.ncbi.nlm.nih.gov/30879324/

onlinelibrary.wiley.com/doi/full/10.10…
This is concerning 🧐, as most RCTs on use of #MCS in #cardiogenicshock focus on patients with #myocardialinfarction and exclude those with #heartfailure related #cardiogenicshock resulting in an overall low level of evidence for this patient population
pubmed.ncbi.nlm.nih.gov/34145680/
Read 10 tweets
🔥Review on optimal targets in #CardiogenicShock in @JACCJournals #Advances by @benhibbertMDPhD & team 👏
Clinical, biochemical & hemodynamic targets to guide therapy & escalation of therapy.
@Sadeer_AlKindi @baileyannRN #ACCEarlyCareer #ACCFIT
👉jacc.org/doi/10.1016/j.…
Current guidelines focus on the t/t of inciting event & restore end-organ perfusion; inotropes/pressors to target MAP ≥65 mm Hg.
🏷 Asses serial markers of systemic perfusion- lactate, ScVO2, UOP, Cr, LFTs, mentation, temp, and invasive hemodynamics & target accordingly
🏷Difference in #SCAI classes A-B & C-E is presence of hypoperfusion- clinical signs like cool mottled skin, poor UOP, confusion, & biochemical abnormalities like ⬆️ lactate, renal insufficiency, and ⬆️ LFTs.
🏷 RAP, ⬆️ shock stage over time, and late deterioration ⬆️ mortality
Read 21 tweets
Don’t miss a new accredited #tweetorial launching Monday here on @cardiomet_CE. Our newest core faculty member, #interventionalist & #SoMe education enthusiast @aayshacader will be discussing #antiplatelet tx in an oh-so-tough scenario--#cardiogenicshock complicating #STEMI.
1) Welcome to a tweetorial on antiplatelet therapy for #STEMI in #cardiogenic shock #CS! Accredited for 0.50 credits by @academiccme! I am @aayshacader. Be sure to see prior tweetorials on this topic and still earn credit at cardiometabolic-ce.com/category/plate… Image
Read 47 tweets
On this day, 20 years ago #September11 , I was attending the CVICU Service @BSWHTemple_IMED .

It was a very busy service and I was pre-rounding.

While listening to a patient’s chest, she gasped.

I took my stethoscope out of my ears and looked at a face of a woman in shock🧵
…not #CardiogenicShock , but this shock.

I sat on her bed and we watched together…in shock

I don’t know how many more minutes it was, but I eventually turned back to her.

She hugged me harder than I’ve ever been hugged before or since.

We cried a few tears 2/
I told her that she was going to be alright…that WE were going to be alright & pat her on the shoulder as I resumed my exam.

As I turned to leave the room, the other plane hit. I looked at her & asked her if she was okay we me leaving. She said, “Yes, you have work to do” 3/
Read 10 tweets
1. Hot off the press - #EHJACVC Issue 1/2021 tweetorial 🔽

The issue opens with an editorial by new EiC @VranckxPascal, highlighting the aims of the journal, presenting the new editorial board and thanking @cvrints, former EiC academic.oup.com/ehjacc/article…

#ACVC_ESC #cardiotwitter
2. Issue focus: #CardiogenicShock (CS) management.

In the new "Sciencepulse", chaired by @ingo_ahrens, David Morrow from @BrighamWomens and @thiele_holger discuss differences and commonalities in CS management in Europe and North America academic.oup.com/ehjacc/article…
3. In an editorial titled "Potential growth in cardiogenic shock research though an international registry collaboration", @seanvandiepen and Dave Morrow call for a Hub-of-Spokes model in #CardiogenicShock research academic.oup.com/ehjacc/article…

#EHJACVC #CardioEd
Read 16 tweets
Kicking off @CRT_meeting #CardiogenicShock sessions: Pathophysiology by @drmortkern...
Don’t forget the RV: by #DrJamesGoldstein...
Trials and evidence (presence and absence) in #Shock treatment: by @thiele_holger...
Read 25 tweets
Have you registered for the upcoming CSRC meeting? Join me & others from academia, industry, & regulatory agencies for a follow-up #CardiogenicShock Think Tank on July 24! Register here: bit.ly/2PtxKoE @CardiacSafety
For my part, I'll be talking about the possibility of Randomized, Embedded, Multifactorial, Adaptive, Platform trials and whether they could be a useful tool in generating evidence for the treatment of cardiogenic shock.
This is especially timely in light of the news that the critical care world has just launched the first #REMAP trial in the US:

Read 3 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!